E70.21 Tyrosinemia

Name of the Condition

• Tyrosinemia (ICD-10 Code: E70.21)

Summary

Tyrosinemia is a rare genetic disorder that impairs the body's ability to metabolize the amino acid tyrosine. This disruption leads to the accumulation of toxic metabolites, which can cause liver, kidney, and neurological complications. Early diagnosis and management are essential to reduce long-term damage.

Causes

Tyrosinemia is caused by genetic mutations that affect enzymes in the tyrosine metabolic pathway. These mutations prevent the proper breakdown of tyrosine, resulting in the buildup of harmful substances. The condition is typically inherited in an autosomal recessive pattern.

Risk Factors

• Genetic predisposition; family history of metabolic disorders.
• Consanguinity (parents who are close relatives).
• Certain ethnic groups with higher carrier rates for specific mutations.

Symptoms

• Liver dysfunction, including jaundice, hepatomegaly, or liver failure.
• Kidney issues, such as renal tubular dysfunction or Fanconi syndrome.
• Neurological symptoms like developmental delay, seizures, or peripheral neuropathy.
• Skin lesions, such as painful palmoplantar hyperkeratosis.
• Failure to thrive or growth retardation in severe cases.

Diagnosis

Diagnosis involves biochemical testing for elevated tyrosine or its metabolites in blood or urine. Genetic testing may confirm the specific enzyme deficiency. Imaging or biopsy may assess organ damage.

Treatment Options

Treatment focuses on reducing tyrosine intake through dietary restrictions and specialized formulas. Medications like nitisinone may help manage metabolite buildup. Liver or kidney transplantation may be necessary in severe cases.

Prognosis and Follow-Up

Prognosis depends on early detection and adherence to treatment. Regular monitoring of liver and kidney function, growth, and neurological status is critical. Lifelong management is often required to prevent complications.

Complications

• Progressive liver disease, including cirrhosis or hepatocellular carcinoma.
• Renal failure or electrolyte imbalances.
• Neurological damage, such as intellectual disability or seizures.
• Increased risk of liver cancer in untreated cases.

Lifestyle & Prevention

• Strict adherence to a low-tyrosine diet to avoid metabolite accumulation.
• Regular follow-up with metabolic specialists and dietitians.
• Avoidance of medications or supplements containing tyrosine without consultation.

When to Seek Professional Help

Seek immediate medical attention for symptoms like jaundice, severe abdominal pain, seizures, or unexplained lethargy. Early evaluation is crucial to prevent irreversible organ damage.

Tips for Medical Coders

Document the specific type of tyrosinemia (e.g., type I, II, or III) when available, as this may impact coding specificity. Include details on diagnostic tests, treatment plans, and organ involvement to support accurate code assignment. Ensure documentation aligns with clinical findings to reflect the condition's severity and management.